Mejopac 100 – Paclitaxel Protein Bound Particles 100 mg Suspension for Injection is a powerful anti-cancer medication used primarily for the treatment of breast cancer, pancreatic cancer, and non-small cell lung cancer. This medication is formulated as a suspension for injection, enabling healthcare professionals to deliver it directly to patients. With a focus on targeting cancerous cells, Mejopac 100 functions by disrupting the microtubule structures within the cancer cells, effectively inhibiting their growth and reproduction. It is essential that the administered dosage and frequency are determined and monitored by a qualified healthcare provider according to the specific needs of the patient. The composition ensures that the active ingredient, Paclitaxel, is protein-bound, enhancing its efficacy while potentially reducing side effects. As with any cancer treatment, patients may experience side effects, which can be managed by healthcare professionals. Mejopac 100 is manufactured by MBA Pharmaceuticals Pvt Ltd in India and should be stored below 30°C. Regular blood tests are necessary to monitor the patient's response to treatment and manage any potential side effects effectively. As a potent chemotherapeutic agent, Mejopac 100 offers hope for many patients battling serious cancers, with treatments tailored to meet their individual health profiles.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Paclitaxel Protein Bound Particles |
| Dosage Form | Suspension for Injection |
| Indications | Breast cancer, non-small cell lung cancer, pancreatic cancer |
| Manufacturer | MBA Pharmaceuticals Pvt Ltd |
| Country of Origin | India |
| Storage Instructions | Store below 30°C |
| Administration | Administered by qualified healthcare professional |
| Side Effects | Common: nausea, vomiting, weakness. Serious: hair loss, low blood cell counts. |
| Attributes | Description |
|---|---|
| Composition | Paclitaxel Protein Bound Particles 100 mg |
| Packing | 1 Vial |
| Therapeutic Class | Anticancer medication |
| Usage | Treatment of cancer |
| Initial Learning Period | Several weeks to months |
| Requires Monitoring | Regular blood tests for blood count and liver function |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Country Of Origin: India
Mejopac 100 – Paclitaxel Protein Bound Particles 100 mg
Composition : Paclitaxel Protein Bound Particles Suspension for Injection 100 mg
Dosage Form: Injection
Packing: 1 Vial
Market Authorization: MBA Pharmaceuticals Pvt Ltd
Country of Origin: India
Store below 30°C
Mejopac 100 – Paclitaxel Protein Bound Particles Suspension for Injection is an anti-cancer medication used in the treatment of breast cancer, pancreatic cancer, and non-small cell lung cancer.
This medication is administered as an injection by a qualified healthcare professional. Your doctor will determine the appropriate dosage and frequency based on your specific condition, which may be adjusted over time. It is crucial to follow your doctor’s instructions precisely. Taking this medication incorrectly or in excessive amounts can lead to serious side effects. It may take several weeks or months to notice the benefits, so continue with the treatment unless advised otherwise by your doctor.
Common side effects of Mejopac – Paclitaxel Protein Bound Particles include nausea, vomiting, and weakness. Serious side effects may also occur, such as swelling of the hands and lips, hair loss, and weight gain. To manage these side effects, your doctor may prescribe additional medication. However, if you notice symptoms such as unexplained bruising or bleeding, a sore throat, mouth ulcers, or a high temperature (fever), inform your doctor immediately. This medication may lower the number of red and white blood cells in your body, increasing your susceptibility to infections. Regular blood tests are necessary to monitor your blood cell count and liver function.
Before starting this treatment, inform your doctor if you have heart disease, liver or kidney problems, or if you are taking any medications for infections. Mejopac – Paclitaxel Protein Bound Particles can interact with other medications, so it is important to inform your healthcare team about all the medicines you are taking. This medication is not recommended during pregnancy or while breastfeeding. Both males and females should use effective contraception during treatment to prevent pregnancy.
Uses of Mejopac 100 – Paclitaxel Protein Bound Particles Suspension for Injection
Breast Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Benefits of Mejopac 100 – Paclitaxel Protein Bound Particles Suspension for Injection
In Breast Cancer:
Mejopac 100 helps in the treatment of breast cancer, either alone or in combination with other medications or treatments like chemotherapy. It alleviates symptoms associated with breast cancer, such as breast lumps, bloody discharge from the nipples, or changes in the shape or texture of the breast. Mejopac 100 works by killing or inhibiting the growth of cancer cells and preventing their multiplication. If any side effects concern you, discuss them with your doctor.
Side Effects of Mejopac 100 – Paclitaxel Protein Bound Particles Suspension for Injection
Most side effects are mild and usually do not require medical attention, as they tend to diminish as your body adjusts to the medication. However, consult your doctor if they persist or if you are concerned about them.
Common Side Effects of Mejopac 100:
How to Use Mejopac 100 for Injection
Your doctor or nurse will administer this medicine to you. Please do not self-administer.
How Mejopac 100 for Injection Works
Mejopac 100 Suspension for Injection is an anticancer medication. It functions by interfering with the microtubule structures that assist cancer cells in dividing and multiplying. This action slows down the growth of cancer cells and ultimately kills them.
Inclusive of all taxes
You Save: 0
